Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group studyMarilyn L. Slovak, Frederick R. Appelbaum, Cheryl L. Willman et al.|Blood|2000Cited by 1.6k
Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.Bruce D. Cheson, Michael J. Keating, Peter A. Cassileth et al.|Journal of Clinical Oncology|1990Cited by 785
Phase I-II trial of mitoxantrone in acute leukemia.Arlin Za, Gary Dukart, R Silver et al.|PubMed|1985Cited by 51
Phase I–II trial of mitoxantrone in acute leukemia: an interim reportZalmen A. Arlin, Gary Dukart, Ingrid Schoch et al.|Investigational New Drugs|1985Cited by 22